Gene: AHSA1
Official Full Name: activator of HSP90 ATPase activity 1provided by HGNC
Gene Summary: Enables ATPase activator activity; Hsp90 protein binding activity; and protein-folding chaperone binding activity. Involved in positive regulation of ATP-dependent activity. Located in cytosol. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06350 | AHSA1 Knockout cell line (HeLa) | Human | AHSA1 | 1:3~1:6 | Negative | Online Inquiry |
KO06351 | AHSA1 Knockout cell line (HCT 116) | Human | AHSA1 | 1:2~1:4 | Negative | Online Inquiry |
KO06352 | AHSA1 Knockout cell line (HEK293) | Human | AHSA1 | 1:3~1:6 | Negative | Online Inquiry |
KO06353 | AHSA1 Knockout cell line (A549) | Human | AHSA1 | 1:3~1:4 | Negative | Online Inquiry |
AHSA1 Gene Knockout Cell Lines are a suite of scientifically engineered cell lines lacking the AHSA1 gene, which encodes for the co-chaperone protein involved in the heat shock response and protein folding processes. These cell lines are pivotal for researchers investigating the biological roles of AHSA1 in various physiological conditions, including stress responses and cellular signaling pathways. By promoting the degradation of misfolded proteins and facilitating the proper folding of newly synthesized proteins, AHSA1 contributes significantly to cellular homeostasis.
The creation of AHSA1 Gene Knockout Cell Lines involves advanced gene editing techniques, such as CRISPR/Cas9, which ensures a precise deletion of the AHSA1 gene. This knockout enables scientists to delineate the specific functions and regulatory mechanisms of AHSA1 in tumorigenesis, neurodegenerative diseases, and response to therapeutic agents, thereby enhancing our understanding of pathophysiological mechanisms and potential treatment targets.
In research and clinical applications, these cell lines are invaluable for drug discovery, toxicity testing, and fundamental biological research. The ability to study cellular processes in the absence of AHSA1 allows for a clearer interpretation of data and the development of therapies that can potentially mitigate the negative effects of aberrant protein management.
The distinctive advantages of AHSA1 Gene Knockout Cell Lines include the replicability of results across multiple experiments and their compatibility with high-throughput screening methodologies, making them an exceptional choice compared to traditional cell lines that may produce confounding results due to variable expression levels of genes. Researchers and clinicians can trust these tools to yield reliable and reproducible outcomes that advance their work in cellular biology.
Our company is dedicated to providing high-quality biological products that empower the scientific community. With extensive experience in genetic engineering and a commitment to innovation, we offer AHSA1 Gene Knockout Cell Lines that are rigorously validated for use in various experimental contexts, ensuring optimal performance and reliability for scientists worldwide.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.